Novavax Outperforms Rivals After FDA Panel Backs Updated Covid Shots

Novavax Outperforms Rivals After FDA Panel Backs Updated Covid Shots

Vaccine stocks rose Wednesday after a experts recommended including an omicron-fighting component in updated Covid boosters this fall.